Legal & General Group
AGN

Legal & General Group’s Allergan plc AGN Stock Holding History

Legal & General Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,101,616
Closed -$372M – 3553
2020
Q1 		$372M Buy
2,101,616
+7,142
+0.3% +$1.34M 0.22% 99
2019
Q4 		$400M Buy
2,094,474
+46,332
+2% +$8.36M 0.19% 117
2019
Q3 		$345M Sell
2,048,142
-5,681
-0.3% -$926K 0.18% 128
2019
Q2 		$344M Sell
2,053,823
-4,985
-0.2% -$690K 0.19% 120
2019
Q1 		$301M Buy
2,058,808
+392,575
+24% +$56.9M 0.17% 132
2018
Q4 		$223M Buy
1,666,233
+106,894
+7% +$17.5M 0.17% 135
2018
Q3 		$297M Sell
1,559,339
-32,999
-2% -$6.06M 0.21% 104
2018
Q2 		$266M Sell
1,592,338
-31,075
-2% -$4.99M 0.2% 110
2018
Q1 		$273M Sell
1,623,413
-115,010
-7% -$19.3M 0.21% 108
2017
Q4 		$284M Sell
1,738,423
-987
-0.1% -$177K 0.21% 111
2017
Q3 		$356M Buy
1,739,410
+87,953
+5% +$20.5M 0.27% 82
2017
Q2 		$401M Buy
1,651,457
+43,015
+3% +$10.1M 0.32% 64
2017
Q1 		$384M Sell
1,608,442
-70,088
-4% -$16.3M 0.33% 64
2016
Q4 		$352M Buy
+1,678,530
New +$348M 0.33% 62
2013
Q4 		– Sell
-559,714
Closed -$80.6M – 1320
2013
Q3 		$80.6M Buy
559,714
+10,384
+2% +$1.38M 0.11% 223
2013
Q2 		$69.3M Buy
+549,330
New +$62.2M 0.1% 246

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Legal & General Group's AGN Position: Q2 2020 in Review

Legal & General Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,101,616 shares — an estimated $372M sold.

Legal & General Group first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $401M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Legal & General Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Legal & General Group sold 2,101,616 Allergan plc shares in Q2 2020, an estimated $372M.
  • Legal & General Group first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • Legal & General Group's Allergan plc position peaked at $401M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.